ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2022 – June 2023. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Fourth quarter (2023-04-01 – 2023-06-30) The Group's net sales amounted to SEK 38 418 (14 233) The Group's loss after financial items amounted to SEK -1 896 506 (-2 378 022) Result per share amounted to SEK -0,12 (-0,16)* Fiscal year (2022-07-01 – 2023-06-30) The Group's net sales amounted to SEK 139 457 (544 151)